Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 20, Issue 12, 2005, Pages 2751-2758

  Grooteman, Muriel P C ^a,b   Gritters, Mareille ^c   Wauters, Inge M P M J ^a   Schalkwijk, Casper G ^a,b   Stam, Frank ^a,b   Twisk, Jos ^a   ter Wee, Piet M ^a,b   Nubé, Menso J ^a,b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Location Alkmaar   (Netherlands)

Author keywords

Cardiovascular disease; Endothelial dysfunction; Haemodialysis; Platelet activation; Soluble cellular adhesion molecules; Von Willebrand factor

Indexed keywords

CELL ADHESION MOLECULE; CUPROPHANE; INTERCELLULAR ADHESION MOLECULE 1; POLYETHERSULFONE; POLYSULFONE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLOOD CELL; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VARIANCE;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CROSS-OVER STUDIES; DIALYSIS SOLUTIONS; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS;

EID: 27944450827     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi126     Document Type: Article

References (20)

1. Jungers P, Massy ZA, Khoa TN et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602
2. Garg AX, Clark WF, Haynes KB, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney Int 2002; 61: 1486-1494
3. Cines DB, Pollak ES, Buck CA et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561
4. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101
5. Papagianni A, Kalovoulos M, Kirmizis D et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 113-119
6. van der Meer IM, de Maat MPM, Bots ML et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis - the Rotterdam study. Arterioscler Thromb Vascular Biol 2002; 22: 838-842
7. Blankenberg S, Rupprecht HJ, Bickel C et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336-1342
8. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92
9. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association, with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 2000; 15: 1624-1630
10. Landray MJ, Wheeler DC, Lip GYH et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004; 43: 244-253
11. Stam F, van Guldener C, Schalkwijk CG et al. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 2003; 18: 892-898
12. Papayianni A, Alexopoulos E, Giamalis P et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant 2002; 17: 435-441
13. Mrowka C, Heintz B, Sieberth HG. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Clinical Nephrology 1999; 52: 312-321
14. Schmitt GW, Moake JL, Rudy CK, Vicks SL, Hamburger RJ. Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis. Am J Med 1987; 83: 411-418
15. Borawski J, Naumnik B, Pawlak K, Mysliwiec M. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response. Nephrol Dial Transplant 2001; 16: 1442-1447
16. Rabb H, Calderon E, Bittle PA, Ramirez G. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients. Am J Kidney Dis 1996; 27: 239-243
17. Gastaldello K, Husson C, Wens R, Vanherweghem JL, Tielemans C. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. Nephrol Dial Transplant 2000; 15: 1638-1646
18. Tielemans CL, Delville JP, Husson CP et al. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 1993; 39: 158-165
19. Gritters M, Grooteman MPC, Schoorl M et al. Citrate anticoagulation abolishes both PMN and platelets degranulation and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant; Advanced Access published 6 September 2005, 10.1093/ndt/gfi069
20. Lonnemann G. Chronic inflammation in hemodialysis: The role of contaminated dialysate. Blood Purification 2000; 18: 214-223